Clinical trial
Evaluation of Improved Onboard Patient Imaging With the HyperSight Platform on TrueBeam 4.1
NCT06187103 is registered in ClinicalTrials.gov with Varian, a Siemens Healthineers Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Improved Onboard Patient Imaging With the HyperSight Platform on TrueBeam 4.1
- Lead sponsor
- Varian, a Siemens Healthineers Company
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 10, 2024
- Completion date
- December 31, 2026
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, head and neck cancer, lung cancer, pelvic cancer, upper gastrointestinal cancer